GB9402641D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9402641D0
GB9402641D0 GB9402641A GB9402641A GB9402641D0 GB 9402641 D0 GB9402641 D0 GB 9402641D0 GB 9402641 A GB9402641 A GB 9402641A GB 9402641 A GB9402641 A GB 9402641A GB 9402641 D0 GB9402641 D0 GB 9402641D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9402641A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Co PLC
Original Assignee
Boots Co PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co PLC filed Critical Boots Co PLC
Priority to GB9402641A priority Critical patent/GB9402641D0/en
Publication of GB9402641D0 publication Critical patent/GB9402641D0/en
Priority to AU15782/95A priority patent/AU1578295A/en
Priority to IL11260295A priority patent/IL112602A0/en
Priority to PCT/EP1995/000440 priority patent/WO1995021615A1/en
Priority to ZA951088A priority patent/ZA951088B/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB9402641A 1994-02-11 1994-02-11 Therapeutic agents Pending GB9402641D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB9402641A GB9402641D0 (en) 1994-02-11 1994-02-11 Therapeutic agents
AU15782/95A AU1578295A (en) 1994-02-11 1995-02-09 Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
IL11260295A IL112602A0 (en) 1994-02-11 1995-02-09 N,n-dimethyl-1-Ú1-(4-chlorophenyl)cyclobutyl¾-3-methylbutylamine in the treatment of epilepsy
PCT/EP1995/000440 WO1995021615A1 (en) 1994-02-11 1995-02-09 Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
ZA951088A ZA951088B (en) 1994-02-11 1995-02-10 Use of substituted arylcyclobutylalkylamine compounds in the treatment of seizures neurological disorders and neurological damage

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9402641A GB9402641D0 (en) 1994-02-11 1994-02-11 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9402641D0 true GB9402641D0 (en) 1994-04-06

Family

ID=10750231

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9402641A Pending GB9402641D0 (en) 1994-02-11 1994-02-11 Therapeutic agents

Country Status (5)

Country Link
AU (1) AU1578295A (en)
GB (1) GB9402641D0 (en)
IL (1) IL112602A0 (en)
WO (1) WO1995021615A1 (en)
ZA (1) ZA951088B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5794887A (en) 1995-11-17 1998-08-18 Komerath; Narayanan M. Stagnation point vortex controller
AU2007200334B8 (en) * 1998-08-24 2010-10-21 Sepracor, Inc. Methods of using and compositions comprising dopamine reuptake inhibitors
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6331571B1 (en) * 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6323242B1 (en) 1998-12-02 2001-11-27 Peter Sterling Mueller Treatment of disorders secondary to organic impairments
US6696495B2 (en) 1998-12-02 2004-02-24 Snowden Pharmaceuticals, Llc Treatment of disorders secondary to organic impairments
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US6288125B1 (en) * 2000-03-17 2001-09-11 Knoll Pharmaceuticals Company Treatment of hiatial hernia
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
CN101098850B (en) 2005-01-06 2010-09-15 Cj第一制糖株式会社 Inorganic acid salts of sibutramine
KR20060080818A (en) 2005-01-06 2006-07-11 씨제이 주식회사 A sulphonic acid salt of sibutramine
KR20060080817A (en) * 2005-01-06 2006-07-11 씨제이 주식회사 A dicarboxylic acid salt of sibutramine
CN102786444A (en) * 2012-07-24 2012-11-21 上海瑞博化学有限公司 Preparation method for sulfonates of sibutramine analogues

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526656A (en) * 1967-05-25 1970-09-01 Parke Davis & Co (1-arylcyclobutyl)carbonyl carbamic acid derivatives
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver
AU4542893A (en) * 1992-06-23 1994-01-24 Sepracor, Inc. Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine

Also Published As

Publication number Publication date
AU1578295A (en) 1995-08-29
WO1995021615A1 (en) 1995-08-17
IL112602A0 (en) 1995-12-08
ZA951088B (en) 1996-01-23

Similar Documents

Publication Publication Date Title
GB9417956D0 (en) Therapeutic agents
GB9418545D0 (en) Therapeutic agents
GB9415996D0 (en) Therapeutic agents
GB9415997D0 (en) Therapeutic agents
GB9417310D0 (en) Therapeutic agents
GB9416189D0 (en) Therapeutic agents
GB9416162D0 (en) Therapeutic agents
GB9402641D0 (en) Therapeutic agents
GB9410031D0 (en) Therapeutic agents
GB9411955D0 (en) Therapeutic agents
GB9415575D0 (en) Therapeutic agents
GB9409264D0 (en) Therapeutic agents
GB9401879D0 (en) Therapeutic agents
GB9403639D0 (en) Therapeutic agents
GB9401642D0 (en) Therapeutic agents
GB9415553D0 (en) Therapeutic agents
GB9416160D0 (en) Therapeutic agents
GB9416427D0 (en) Therapeutic agents
GB9416428D0 (en) Therapeutic agents
GB9415910D0 (en) Therapeutic agents
GB9415805D0 (en) Therapeutic agents
GB9415783D0 (en) Therapeutic agents
GB9415745D0 (en) Therapeutic agents
GB9411993D0 (en) Therapeutic agents
GB9419894D0 (en) Therapeutic agents